Docstoc

Renal Atheroembolic Disease

Document Sample
Renal Atheroembolic Disease Powered By Docstoc
					                                      Renal Atheroembolic Disease
Tunick et al, Clinical Characteristics of Renal Atheroemboli, Uptodate
Fukumoto et al, Incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac
catheterization: a prospective study. JACC 2003; 42:211.
Scolari, The Challenge of disagnosing atheroembolic renal disease: clinical features and prognostic factors.
Circulation 2007; 116:298

Introduction
     Renal atheroembolic disease occurs most often in older patients with diffuse erosive
        atherosclerosis
     Crystal emboli occurs with atherosclerotic plaque breaks off and embolizes distally
        causing occlusion of multiple small arteries
     Lesions can be either inflammatory or ischemic
Risk Factors
     Often seen after manipulation of the aorta after vascular interventions, can be
        spontaneous as well
     Aorta most common source of crystals, so can also see embolization to the kidneys,
        interstines, and legs
Incidence
     Probably underdiagnosed
     Some studies place incidence at 1.5-2%
     One large JACC study showed incidence after cardiac cath to be 1.5%
Clinical Characteristics
     Usually associated with multiple emboli to small arteries
     Associated with other extra-renal manifestations, i.e. blue toe syndrome, livedo
        reticularis, GI manifestations
     While clot emboli present with flank pain and hematuria from complete occlusion of a
        large vessels atheroembolic disease generally results in incomplete occlusion causing
        ischemic atrophy
     Cholesterol crystals also cause a foreign body reaction in the vessel wall which also may
        explain clinical presentation
     May present acutely, but more commonly presents as progressive decline in renal
        function 3-8 weeks after inciting event
     Two clinical scenarios: a) Marked renal impairment days to 1-2 weeks after vascular
        procedure or anti-coagulation; b) Subuaccute presentation weeks after an insult with
        stepwise degradation in renal function
Labs
     UA shows mild sediment with few cells or casts, proteinuria is not a common feature
     Eosinophilia and hypocomplemntemia are associated with disease, and can present in a
        more active phase
     Biopsy in some cases may be necessary, can see characteristic cholesterol crystals on
        examination
Treatment and Prognosis
     No good treatment, prognosis is poor (30% at 24 months)
     Leading cause of death is cardiovascular
     Aggressive treatment for secondary prevention of cardiovascular disease
     May be some benefit to statin therapy (plaque stabilization) in particular

				
DOCUMENT INFO